Page last updated: 2024-11-06

indole-3-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Indole-3-carboxylic acid (ICA) is a naturally occurring heterocyclic compound found in various plants and microorganisms. It exhibits a wide range of biological activities, including antibacterial, antifungal, anti-inflammatory, and anticancer properties. ICA is a key intermediate in the biosynthesis of tryptophan, an essential amino acid. It is also a precursor to the synthesis of several important natural products, such as indigo, a blue dye, and auxin, a plant hormone. Researchers are interested in ICA for its potential applications in medicine, agriculture, and other fields. For instance, it has shown promising results in treating bacterial infections, promoting plant growth, and inhibiting tumor cell proliferation.'

indole-3-carboxylic acid : An indole-3-carboxylic acid carrying a carboxy group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID69867
CHEMBL ID387527
CHEBI ID24809
SCHEMBL ID64182
MeSH IDM0059354

Synonyms (72)

Synonym
EN300-13123
SDCCGMLS-0065969.P001
einecs 212-231-6
771-50-6
CHEBI:24809 ,
1h-indole-3-carboxylic acid
indole-3-carboxylic acid
OPREA1_560034
inchi=1/c9h7no2/c11-9(12)7-5-10-8-4-2-1-3-6(7)8/h1-5,10h,(h,11,12
indole-3-carboxylic acid, reagentplus(r), 99%
ico ,
I-2320
STK500561
AC-2264
3-indoleformic acid
CHEMBL387527
AKOS001071938
F2147-0150
I0028
3-indoleformic acid;indole-3-carboxylic acid
A9767
3-carboxyindole
1-(2-methoxyphenyl)piperazinehydrochloride
indole-3-carboxylicacid
C19837
3-indolecarboxylic acid
unii-59711r38b0
59711r38b0 ,
bdbm93015
FT-0627218
4AHU
S4860
SCHEMBL64182
AB00443727-03
indole 3-carboxylic acid
indole-3 carboxylic acid
FS-1053
SY004104
mfcd00005624
DTXSID50227886
.beta.-indolylcarboxylic acid
3-indolylcarboxylic acid
tropisetron hydrochloride impurity b [ep impurity]
indole-.beta.-carboxylic acid
J-400967
beta-indolylcarboxylic acid
Q-102571
CS-D0682
indole-3-carboxylic acid, purum, >=98.0% (t)
indole - 3 carboxylate
indole - 3 carboxylic acid
3-indolylcarboxylate
3-indolecarboxylate
3-indole carboxylic acid
3-indoleformate
indole-3-carboxylic acid, vetec(tm) reagent grade, 98%
tropisetron impurity b, european pharmacopoeia (ep) reference standard
tropisetron hydrochloride imp. b (ep); tropisetron imp. b (ep); 1h-indole-3-carboxylic acid; tropisetron hydrochloride impurity b; tropisetron impurity b
Z89283908
3-indole carboxylic
3-indolecarboxylicacid
Q27103090
BCP26648
indole-3-carboxylic acid pound>>1h-indole-3-carboxylic acid pound>>3-carboxyindole
3-indolecarboxylic
SB14951
AMY2761
HY-40161
CCG-266287
indole-3-carboxylic acid, 99%
NCGC00323250-01
tropisetron impurity b
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
indol-3-yl carboxylic acidAny indolyl carboxylic acid carrying an indol-3-yl or substituted indol-3-yl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chymotrypsinogen ABos taurus (cattle)Ki5,250.00000.90004.00008.7000AID1799873
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
digestionChymotrypsinogen ABos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
protein bindingChymotrypsinogen ABos taurus (cattle)
serpin family protein bindingChymotrypsinogen ABos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
extracellular regionChymotrypsinogen ABos taurus (cattle)
serine protease inhibitor complexChymotrypsinogen ABos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID356737Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Antioxidant principles from Bauhinia tarapotensis.
AID360810Inhibition of tyrosin kinase pp60src1995Journal of natural products, Dec, Volume: 58, Issue:12
Chemical constituents of halophilic facultatively anaerobic bacteria, 1.
AID329525Activity at androgen receptor ligand binding domain assessed as inhibition of SRC2-3 interaction at 50 uM after 2 hrs by fluorescence polarization assay2007Proceedings of the National Academy of Sciences of the United States of America, Oct-09, Volume: 104, Issue:41
A surface on the androgen receptor that allosterically regulates coactivator binding.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1467207Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced NO production pretreated for 30 mins followed by LPS stimulation for 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 06-15, Volume: 27, Issue:12
Alkaloids from aerial parts of Houttuynia cordata and their anti-inflammatory activity.
AID356738Antioxidant activity against beta-carotene and linoleic acid assessed asbleaching of beta-carotene at 120 mins by autooxidation assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Antioxidant principles from Bauhinia tarapotensis.
AID1780506Inverse agonist activity at Gal4-fused human Nurr1 LBD expressed in HEK293T cells co-expressing firefly luciferase assessed as luciferase activity by hybrid reporter gene assay2021Journal of medicinal chemistry, 10-28, Volume: 64, Issue:20
Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1.
AID1372697Inhibition of mushroom tyrosinase using tyrosine as substrate pretreated for 5 mins followed by substrate addition measured after 20 mins by ELISA2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Characterization of tyrosinase inhibitory constituents from the aerial parts of Humulus japonicus using LC-MS/MS coupled online assay.
AID356735Antioxidant activity against beta-carotene and linoleic acid assessed asbleaching of beta-carotene at 60 mins by autooxidation assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Antioxidant principles from Bauhinia tarapotensis.
AID1867354Dissociation constant, pKa of the compound by dip probe absorption spectroscopy2022European journal of medicinal chemistry, Jul-05, Volume: 237The azulene scaffold from a medicinal chemist's perspective: Physicochemical and in vitro parameters relevant for drug discovery.
AID1799873Kinetic Assay from Article 10.1021/bi00877a017: \\INTERACTION OF AROMATIC COMPOUNDS WITH ALPHA-CHYMOTRYPSIN. II. COMBINATION OF THE ISOMERIC INDOLE CARBOXAMIDES AND CARBOXYLATE IONS WITH THE ACTIVE SITE.\\1965Biochemistry, Jan, Volume: 4INTERACTION OF AROMATIC COMPOUNDS WITH ALPHA-CHYMOTRYPSIN. II. COMBINATION OF THE ISOMERIC INDOLE CARBOXAMIDES AND CARBOXYLATE IONS WITH THE ACTIVE SITE.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Journal of biomolecular screening, Feb, Volume: 18, Issue:2
Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (64)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (10.94)18.7374
1990's4 (6.25)18.2507
2000's10 (15.63)29.6817
2010's33 (51.56)24.3611
2020's10 (15.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.28 (24.57)
Research Supply Index4.17 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index43.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (98.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]